← Back
$AKRO All transactions

Akero Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$264K

Shares

12,500

Price

$21

Filed

Aug 13

Insider

Name

Young Jonathan

Title

Chief Operating Officer

CIK

0001779805

Roles

Officer

Transaction Details

Transaction Date

2025-08-12

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

209,984

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated April 29, 2025, previously adopted by the Reporting Person. | These shares are held in irrevocable trusts for the benefit of the Reporting Person's children. The Reporting Person's spouse is trustee of the trusts. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $47.21 to $48.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $48.22 to $48.61, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. | This option shall vest and become exercisable in 48 equal monthly installments, commencing on December 8, 2021

Filing Info

Accession No.

0000950170-25-108234

Form Type

4

Issuer CIK

0001744659

Young Jonathan's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.